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underwent a clinical examination, an echocardiogram, an oesophagial echocar-
diogram or other radiologic (CT or MRI), to specify the congenital heart dis-
ease. All patients had an adequate interventional cardiology, surgical care or
medical intervention.
Results: We included 44 patients, 23 cases of atial septal defects (ASD)
with mean age 38 years (16 women and 07 men), 8 ASD closed surgically and
15 by percutaneous routes.
4 patent ductus arteriosus: mean age 32 years (04 women), closed by per-
cutaneous.
4 cases coarctation of the aorta, mean age 32 years (4 women), dilated with
percutaneous procedure. 9 pulmonary stenosis, mean age: 30 years, all patients
underwent balloon dilation. We investigate also one bicuspid aortic with aortic
stenosis and 2 Epstein anomaly.
The outcome was favorable for all patients diagnosed during this period.
Conclusion: Congenital heart defects discovered in adulthood are not
uncommon and should be supported either by medical, surgical, or interven-
tional.
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Pulmonary arterial hypertension after successful arterial switch operation
(ASO) for simple transposition of the great arteries is a rare but important
cause of late morbidity and mortality. However this complication is poorly
characterised in the literature. In Here, we report the prevalence of this condi-
tion and its outcomes from the largest series of ASO procedures yet reported.
Methods: Between January 1985 and June 2011, 1137 arterial switch proce-
dures were performed for simple TGA at the Hôpital Necker Enfants Malades
in Paris. All patients underwent ASO within the early neonatal period. In all
cases, pulmonary pressure was evaluated at routine echocardiography and pul-
monary hypertension was confirmed by right heart catheterisation.
Results: Of 1137 consecutive ASO cases, 8 patients (0.7%, 95% confi-
dence interval 0.29-1.36%) developed severe PAH in the peri-operative period
that persisted beyond 1 month post-operatively requiring PAH targeted
therapy. Three of those resolved with treatment after 3, 4 and 5 months
respectively.
The prevalence of PAH in a general French paediatric population was esti-
mated to be 3.7 per million. These data suggest that long-term survivors of the
ASO have a relative risk for the development of PAH around 2000-fold (point
estimate 1757-fold, 95% confidence interval 785-3932) compared to children
without congenital heart disease.
Conclusion: Pulmonary hypertension is a severe complication of TGA
which must be rapidly detected in order to initiate targeted therapy. Revers-
ibility is indeed not excluded since last cases of our series have normalized
their pulmonary pressure.
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Many devices are available for atrial septal defect (ASD) usually in adults
and children. We report here one center experience in transcatheter closure of
ASD in infancy, using the Amplatzer septal occluder. From January 2003 to
March 2010, 10 males and 5 female, mean age 10.9±6.4 months, with weight
6.7±2.5 kg underwent transcatheter closure of atrial septal defect. The patients
had significant left-to-right shunting (n=12), right-to-left shunting with hypo-
xemia (n=3). For the left-to-right shunting, the ASD was closed for pulmonary
hypertension (n=10), for recurrent chest infection and bronchiolitis (n=5). The
ASD was associated with other congenital heart defect (n=5), prematurity and
bronchopulmonary dysplasia (n=6), foetopathy (n=1) and encephalopathy
(n=1).
The ASD was evaluated by transthoracic echocardiography (TEE) before
the procedure. Percutaneous closure was realized with TEE for all patients.
They received intravenous heparin. For 4 patients implantation was performed
after a balloon test occlusion (mean 11±3.4 mm diameter). The ASO device
size was 10.4±3.9 mm. The fluoroscopy time was 7.9±3.9 minutes and the
time of the procedure 55.6±21.8 minutes. No per procedural complications
were observed for all but for two (one anomalous device deployment and one
insufficient rim). These two patients were subsequently surgically repaired.
Patients left the hospital with a low dose of aspirin for 6 months.
During follow-up, four patients had a minimal residual shunt on TEE per-
formed up to one year after the implantation. No later cardiac complication
was observed.
To conclude, transcatheter closure of atrial septal defect in infant with the
ASO is feasible and a possible alternative to surgical closure. In addition,
ASD occlusion improves the respiratory status and reduces the level of pul-
monary hypertension. Additional long-term results and a large study are both
necessary to establish the future of this population
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Background: Precise features of infants with partial and transitional atrio-
ventricular septal (PAVC) defect requiring surgical repair remain undeter-
mined, as well as their outcome. We retrospectively analyzed this patient
population.
Patients and Method: Cases with single ventricle palliation were excluded.
Since January 1st, 2000, 11 infants (< 1 year of age) underwent surgical repair
of PAVC in our institution, at a median age and weight of 7 (2 to 11) months
and 6.2 (3.4 to 7.8) Kg, respectively. All patients had refractory congestive heart
failure before surgery. Six patients were prenatally diagnosed and 2 had Down
syndrome. Three patients had a small left atrioventricular valve (LAVV) with a
Z-score diameter < – 2. One infant had and associated aortic coarctation neces-
sitating concomitant repair. Other associated cardiac anomalies included persis-
tent left superior vena cava and interrupted inferior vena cava.
Results: All the patients survived after surgical repair, with a median stay
of 2 (1 to 21) days in the intensive care unit. One patient with a parachute
LAVV was reoperated 1 month after surgery for LAVV insufficiency. After a
median follow-up of 4,56 (2,6 to 12,2) years, all the patients are in NYHA
class I, with no medication. Echocardiography shows moderate LAVV insuf-
ficiency in 2 cases.
Conclusion: Surgical repair of PAVC in the first year of life is feasible
with excellent mid-term outcome, even in cases with a small LAVV. Patients
with “parachute like” LAVV may experience significant regurgitation neces-
sitating reoperation.
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Introduction: Syncopes are frequent in the pediatric population. The
majority is benign but, for a minority of children, a cardiac disease is the
underlying cause and has to be recognized as it can be fatal. Syncope units
developped in adult population have demonstrated major improvement in
diagnostic process, hospitalisation reduction time, with favourable long-term
outcome. We report our experience of syncope management in chidren and
adolescents through a dedicated syncope unit.
Methods: In this ongoing prospective study, we enrolled 31 consecutive
patients (13±3 yo, 65% male) between Jan 2011 and Mar 2012, referred for
loss of consciousness (LOC) in a dedicated pediatric syncope unit involving a
pediatric cardiologist, a nurse, a physiotherapist and a psychologist. All
patients underwent initial evaluation including medical history assessment,
physical examination, 12-lead ECG and echocardiography to exclude non-car-
diogenic syncopes. If initial assessement was abnormal, they underwent tar-
geted tests that differed according to suspected aetiology. Patients with
neurocardiogenic syncope underwent specific physiotherapy training and a
consultation with a psychologist.
Results: The most common cause of LOC was neurocardiogenic syncope
– 22 patients (71%), psychogenic LOC – 7 patients (23%). One patient (3%)
had a long QT syndrome and received beta blocker therapy. One patient had
typical epileptic seizure and was transferred to neurologic departement. Mean
hospitalization duration was 0,9±0,5 days. Head-up tilt testing was positive in
62% neurocardiogenic syncope. Echocardiograms and exercise tests were not
contributive for diagnosis. After a mean follow up of 9±4 months, including
physiotherapist and/or phychologist specific care, syncope reccurence occured
in 4 patients (12%).
Conclusion: Syncope unit in pediatric population with dedicated team
improves diagnostic process, reduces hospitalisation and decreases syncope
recurrence when adapted follow up is proposed.
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The aim of this study was to assess the results of ECMO as a perioperative
support in children with congenital heart disease (CHD) during and after
open-heart surgery.
Material and methods: All patients aged < 18 years at surgery who
needed ECMO support from 2004 to 2011, were included in the study. Cli-
nical and biological data, demographics and outcomes were retrospectively
reviewed.
Results: Twenty-seven patients (19 males) (i.e. 0.5% of total pediatric car-
diac surgical procedures performed per year), aged 3days to 18years (mean
1.6years) were placed on ECMO, per-operatively in 10 (37%, for failure to
wean off bypass) or during the early postoperative course in 17 (8 < 24th hour,
9 >24th hour) for cardiac arrest (33%) or low cardiac output (30%). Surgical
repair included: severe form of tetralogy of Fallot (4), complex arterial switch
operation (7), complex left heart obstruction (5), Rastelli (4), ALCAPA (1),
cavopulmonary anastomosis (3) and miscellaneaous (3). Twelve cases were
in-hospital preoperatively, of whom 7 were dependent on mechanical ventila-
tory support.
Five patients died while on ECMO because of multi organ failure (4) or
pulmonary hypertension (1). Main complications during support included
hemorrhages (15 cases), renal failure requiring peritoneal dialysis (14), hemo-
lysis (13), canulas thrombosis (6), and strokes (4). Only 3 cases were free
from complication. Duration of ECMO was 5.4±3.6days (1 to 16, median 5),
of CICU stay 26±16days (10 to 69, median 22). Survival to ECMO was
81.5% (22 patients) and overall survival was 59% (16). Significant predictive
factors for mortality were: preoperative clinical status (in-hospital: 25% in
alive patients versus 73% in deceased cases, p= 0.01), lactates level at onset
of ECMO (mean 6 versus 10, p= 0.004) and duration of aortic clamp (mean
70 versus 110mn, p= 0.05).
Conclusion: This study shows that post-cardiotomy ECMO in children is
a valuable therapeutic option as a bridge to recovery, despite high frequency
of complications on support.
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The myocardial bridge often congenital, is an aberrant relationship between
the trunks and epicardial coronary infarction. Although often asymptomatic,
this detection coronary angiography (effect of “milking” the compression
stroke) was associated with ischemia, heart rhythm disorders and sudden
death.
Ten clinical cases have prompted a review of literature on the morpholo-
gical and functional alterations that characterize patients with myocardial
bridge and the current diagnostic and therapeutic method.
The investigative tools currently available in the catheterization laborato-
ries have clarified how the symptoms and signs of ischemia may occur in
these patients, especially when the only angiographic findings appear to be a
compression stroke or effect “milking” of a coronary. The quantitative coro-
nary angiography and IVUS have clearly demonstrated that systolic compres-
sion phase observed in the angiogram is coupled with a persistent diastolic
diameter reduction. The intra coronary Doppler revealed an increase in the
speed of retrograde flow and reduced coronary reserve. The diagnosis can be
established by a significant reduction in the percentage of luminal diameter
with loss of surface, increasing the flow velocity and characteristic features
such appearance in IVUS lunate aspect and “finger tip” of the diastolic flow
Early in the intra-coronary Doppler. Medical treatment, interventional cathe-
terization and surgery not only allow a significant reduction or normalization
of these alterations, but also a significant improvement in signs of ischemia
and angina episodes. The low rate of clinical manifestations and the variability
of the morphological, functional and clinical preventing the establishment of
solid recommendations for diagnosis and treatment, in light of published cases
in the literature that concern only a limited number.
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Introduction: Ebstein’s disease is a rare congenital malformation with
many clinical manifestations depending on the age at diagnosis and the
severity of the anatomical pattern. In this study we try to describe the clinical
manifestations, the echocardiographic patterns and the outcome of this malfor-
mation in adulthood.
Methods and results: Retrospective study about 8 cases of Ebstein’s
anomaly in adult patients (5 women and 3 men); the mean age is 34 years old.
The clinical manifestations were absent in 6% of cases but the majority of
patients have exertional dyspnea or palpitations in 56% of cases. Arrhythmias
and congestive heart failure were observed respectively in 6% and 13% of
cases. Transthoracic echocardiography demonstrated the presence of Ebstein
anomaly in all cases, showing apical displacement of the septal leaflet of the
tricuspid valve. Five patients had the A grade of the Carpentier’s classification
and the others had the grade B. After an outcome of 11 years, one patient died
by refractory heart failure.
Conclusion: Clinical manifestations and outcome of Ebstein’s anomaly
depend on the degree of tricuspid valve malformation and many cases are dis-
covered in adults. The prognosis is worsening by arrhythmia and heart failure.
Surgical intervention with tricuspid valve repair should be proposed for
patients with severe heart failure and intractable arrhythmia. Conservative sur-
gery and anti arrhythmic therapy had enhanced the prognosis of this conge-
nital malformation.
